Orchid Pharma consolidated net profit declines 49.20% in the June 2025 quarter
Sales decline 29.25% to Rs 172.93 crore
Net profit of Orchid Pharma declined 49.20% to Rs 14.91 crore in the quarter ended June 2025 as against Rs 29.35 crore during the previous quarter ended June 2024. Sales declined 29.25% to Rs 172.93 crore in the quarter ended June 2025 as against Rs 244.41 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales172.93244.41 -29 OPM %8.1913.29 -PBDT22.3736.56 -39 PBT13.7128.12 -51 NP14.9129.35 -49Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 12 2025 | 5:20 PM IST